TTNP.OB Insider Trading Activity and SEC Form 4 Filings
TTNP.OB insider trading summary
No open-market insider purchases or sales of Titan Pharmaceuticals Inc (TTNP.OB) have been reported on SEC Form 4 in the past 12 months.
Latest TTNP.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 21, 2018 | M David Macfarlane | Director | Buy | $20K (80,000 @ $0.25) |
| Jul 19, 2016 | Joseph A Akers | Director | Buy | $23K (5,000 @ $4.68) |
| Jul 18, 2016 | Joseph A Akers | Director | Buy | $40K (8,000 @ $4.95) |
| Jan 11, 2016 | Sunil Bhonsle | President and CEO | Buy | $54K (17,000 @ $3.18) |
| Oct 1, 2015 | Sunil Bhonsle | President | Buy | $798 (200 @ $3.99) |
| Sep 30, 2015 | Sunil Bhonsle | President | Buy | $2K (500 @ $3.98) |
| Sep 28, 2015 | Sunil Bhonsle | President | Buy | $3K (910 @ $3.62) |
| Sep 16, 2015 | Sunil Bhonsle | President | Buy | $4K (5,000 @ $0.70) |
| Sep 15, 2015 | Sunil Bhonsle | President | Buy | $3K (5,000 @ $0.69) |
| Aug 25, 2015 | Sunil Bhonsle | President | Buy | $35K (50,000 @ $0.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.